{"count": 7, "results": [{"_id": "25983864", "pmid": 25983864, "pmcid": "PMC4421160", "title": "Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient", "journal": "NDT Plus", "authors": ["Chanson N", "Bossi P", "Schneider L", "Bourry E", "Izzedine H"], "date": "2008-06-01T00:00:00Z", "doi": "10.1093/ndtplus/sfn012", "meta_date_publication": "2008 Jun", "meta_volume": "1", "meta_issue": "3", "meta_pages": "157-61", "score": 50065.14, "text_hl": "@DISEASE_Rhabdomyolysis @DISEASE_MESH:D012206 @@@Rhabdomyolysis@@@ after @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@/@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ therapy in an @<m>DISEASE_HIV_Infections</m> @DISEASE_MESH:D015658 @@@HIV-infected@@@ patient", "citations": {"NLM": "Chanson N, Bossi P, Schneider L, Bourry E, Izzedine H. Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient NDT Plus. 2008 Jun;1(3):157-61. PMID: 25983864", "BibTeX": "@article{25983864, title={Rhabdomyolysis after ezetimibe/simvastatin therapy in an HIV-infected patient}, author={Chanson N and Bossi P and Schneider L and Bourry E and Izzedine H}, journal={NDT Plus}, volume={1}, number={3}, pages={157-61}}"}}, {"_id": "15659879", "pmid": 15659879, "title": "Rhabdomyolysis after simvastatin therapy in an HIV-infected patient with chronic renal failure.", "journal": "AIDS Patient Care STDS", "authors": ["Moro H", "Tsukada H", "Tanuma A", "Shirasaki A", "Iino N", "Nishibori T", "Nishi S", "Gejyo F"], "date": "2004-12-01T00:00:00Z", "doi": "10.1089/apc.2004.18.687", "meta_date_publication": "2004 Dec", "meta_volume": "18", "meta_issue": "12", "meta_pages": "687-90", "score": 50056.08, "text_hl": "@DISEASE_Rhabdomyolysis @DISEASE_MESH:D012206 @@@Rhabdomyolysis@@@ after @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ therapy in an @<m>DISEASE_HIV_Infections</m> @DISEASE_MESH:D015658 @@@HIV-infected@@@ @SPECIES_9606 @@@patient@@@ with @DISEASE_Kidney_Failure_Chronic @DISEASE_MESH:D007676 @@@chronic renal failure@@@.", "citations": {"NLM": "Moro H, Tsukada H, Tanuma A, Shirasaki A, Iino N, Nishibori T, Nishi S, Gejyo F. Rhabdomyolysis after simvastatin therapy in an HIV-infected patient with chronic renal failure. AIDS Patient Care STDS. 2004 Dec;18(12):687-90. PMID: 15659879", "BibTeX": "@article{15659879, title={Rhabdomyolysis after simvastatin therapy in an HIV-infected patient with chronic renal failure.}, author={Moro H and Tsukada H and Tanuma A and Shirasaki A and Iino N and Nishibori T and Nishi S and Gejyo F}, journal={AIDS Patient Care STDS}, volume={18}, number={12}, pages={687-90}}"}}, {"_id": "18576906", "pmid": 18576906, "title": "Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy.", "journal": "Pharmacotherapy", "authors": ["Rahman AP", "Eaton SA", "Nguyen ST", "Bain AM", "Payne KD", "Bedimo R", "Busti AJ"], "date": "2008-07-01T00:00:00Z", "doi": "10.1592/phco.28.7.913", "meta_date_publication": "2008 Jul", "meta_volume": "28", "meta_issue": "7", "meta_pages": "913-9", "score": 50049.91, "text_hl": "Safety and efficacy of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ for the treatment of @DISEASE_Dyslipidemias @DISEASE_MESH:D050171 @@@dyslipidemia@@@ in @<m>DISEASE_HIV_Infections</m> @DISEASE_MESH:D015658 @@@human immunodeficiency virus-infected@@@ @SPECIES_9606 @@@patients@@@ receiving @CHEMICAL_efavirenz @CHEMICAL_MESH:C098320 @@@efavirenz@@@-based highly active antiretroviral therapy.", "citations": {"NLM": "Rahman AP, Eaton SA, Nguyen ST, Bain AM, Payne KD, Bedimo R, Busti AJ. Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy. Pharmacotherapy. 2008 Jul;28(7):913-9. PMID: 18576906", "BibTeX": "@article{18576906, title={Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy.}, author={Rahman AP and Eaton SA and Nguyen ST and Bain AM and Payne KD and Bedimo R and Busti AJ}, journal={Pharmacotherapy}, volume={28}, number={7}, pages={913-9}}"}}, {"_id": "22475660", "pmid": 22475660, "title": "Use of direct renin inhibitor in an HIV positive subject.", "journal": "Infez Med", "authors": ["Ucciferri C", "Brescini L", "Staffolania S", "Falasca K", "Cirioni O", "Giacometti A", "Vecchiet J"], "date": "2012-03-01T00:00:00Z", "meta_date_publication": "2012 Mar", "meta_volume": "20", "meta_issue": "1", "meta_pages": "49-51", "score": 50044.508, "text_hl": "CASE REPORT: A 61-year-old @<m>DISEASE_HIV_Infections</m> @DISEASE_MESH:D015658 @@@HIV-infected@@@ Caucasian male (CDC C3) @SPECIES_9606 @@@patient@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ for ten years and @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular complications@@@ took @CHEMICAL_Carvedilol @CHEMICAL_MESH:D000077261 @@@carvedilol@@@ 25 mg twice a day, plus daily administration of @CHEMICAL_Irbesartan @CHEMICAL_MESH:D000077405 @@@irbesartan@@@ 300 mg, hydroclorotiazide 25 mg, @CHEMICAL_Doxazosin @CHEMICAL_MESH:D017292 @@@doxazosin@@@ 4 mg, @CHEMICAL_lacidipine @CHEMICAL_MESH:C060285 @@@lacidipine@@@ 6 mg, and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg. ", "citations": {"NLM": "Ucciferri C, Brescini L, Staffolania S, Falasca K, Cirioni O, Giacometti A, Vecchiet J. Use of direct renin inhibitor in an HIV positive subject. Infez Med. 2012 Mar;20(1):49-51. PMID: 22475660", "BibTeX": "@article{22475660, title={Use of direct renin inhibitor in an HIV positive subject.}, author={Ucciferri C and Brescini L and Staffolania S and Falasca K and Cirioni O and Giacometti A and Vecchiet J}, journal={Infez Med}, volume={20}, number={1}, pages={49-51}}"}}, {"_id": "10999499", "pmid": 10999499, "title": "Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection.", "journal": "Pharmacotherapy", "authors": ["Penzak SR", "Chuck SK", "Stajich GV"], "date": "2000-09-01T00:00:00Z", "doi": "10.1592/phco.20.13.1066.35033", "meta_date_publication": "2000 Sep", "meta_volume": "20", "meta_issue": "9", "meta_pages": "1066-71", "score": 50041.75, "text_hl": "Safety and efficacy of HMG-CoA reductase inhibitors for treatment of @DISEASE_Hyperlipidemias @DISEASE_MESH:D006949 @@@hyperlipidemia@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_HIV_Infections</m> @DISEASE_MESH:D015658 @@@HIV infection@@@.", "citations": {"NLM": "Penzak SR, Chuck SK, Stajich GV. Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection. Pharmacotherapy. 2000 Sep;20(9):1066-71. PMID: 10999499", "BibTeX": "@article{10999499, title={Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection.}, author={Penzak SR and Chuck SK and Stajich GV}, journal={Pharmacotherapy}, volume={20}, number={9}, pages={1066-71}}"}}, {"_id": "30808332", "pmid": 30808332, "pmcid": "PMC6390564", "title": "Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya  (EVG/COBI/FTC/TAF) and simvastatin; a case report", "journal": "BMC Nephrol", "authors": ["Godinho R", "Bugnon S", "Gracin T", "Tataw J"], "date": "2019-02-26T00:00:00Z", "doi": "10.1186/s12882-019-1257-6", "meta_date_publication": "2019 Feb 26", "meta_volume": "20", "meta_issue": "1", "meta_pages": "69", "score": 50041.395, "text_hl": "He also had dyslipidaemia which was treated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg for many years. ", "citations": {"NLM": "Godinho R, Bugnon S, Gracin T, Tataw J. Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya  (EVG/COBI/FTC/TAF) and simvastatin; a case report BMC Nephrol. 2019 Feb 26;20(1):69. PMID: 30808332", "BibTeX": "@article{30808332, title={Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya  (EVG/COBI/FTC/TAF) and simvastatin; a case report}, author={Godinho R and Bugnon S and Gracin T and Tataw J}, journal={BMC Nephrol}, volume={20}, number={1}, pages={69}}"}}, {"_id": "26803470", "pmid": 26803470, "title": "A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry.", "journal": "Virology", "authors": ["Esposito AM", "Cheung P", "Swartz TH", "Li H", "Tsibane T", "Durham ND", "Basler CF", "Felsenfeld DP", "Chen BK"], "date": "2016-03-01T00:00:00Z", "doi": "10.1016/j.virol.2015.10.013", "meta_date_publication": "2016 Mar", "meta_volume": "490", "meta_issue": "", "meta_pages": "6-16", "score": 50032.863, "text_hl": "Modest therapeutic indices for @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Nigericin @CHEMICAL_MESH:D009550 @@@nigericin@@@ were observed in confirmatory @<m>DISEASE_HIV_Infections</m> @DISEASE_MESH:D015658 @@@HIV infection@@@ assays. ", "citations": {"NLM": "Esposito AM, Cheung P, Swartz TH, Li H, Tsibane T, Durham ND, Basler CF, Felsenfeld DP, Chen BK. A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry. Virology. 2016 Mar;490():6-16. PMID: 26803470", "BibTeX": "@article{26803470, title={A high throughput Cre-lox activated viral membrane fusion assay identifies pharmacological inhibitors of HIV entry.}, author={Esposito AM and Cheung P and Swartz TH and Li H and Tsibane T and Durham ND and Basler CF and Felsenfeld DP and Chen BK}, journal={Virology}, volume={490}, pages={6-16}}"}}]}